Brief: Kindstar Globalgene Technology Sees Revenue For 1H2022 Within Range Of RMB613 Mln To RMB660 Mln
July 20 (Reuters) - Kindstar Globalgene Technology
9960.HK :
* SEES TOTAL REVENUE FOR 1H2022 TO BE WITHIN RANGE OF
RMB613
MILLION TO RMB660 MILLION
* GROUP EXPECTED TO TURN LOSSES INTO PROFITS FOR 1H2022
* EXPECTED IMPROVEMENTS IN RESULTS DUE TO CO'S
COVID-19-RELATED
TESTING SEGMENT ACHIEVING SUBSTANTIAL GROWTH
Further company coverage: 9960.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kindstar Globalgene Technology
See all newsChina's Kindstar Globalgene H1 loss narrows after oncology testing expansion
Brief: Kindstar Globalgene Technology Posts Full-Year Loss Attributable Of RMB58.7 Million
Brief: Kindstar Globalgene Technology Inc Unit To Buy 40% Of Huaxi Kindstar
Brief: Kindstar Globalgene Technology Expects HY Net Loss Of RMB30-35 Million
Brief: Kindstar Globalgene Technology Sees FY Loss Between RMB55 Million And RMB65 Million